FDA Okays Once-Weekly Tx for Turner Syndrome Growth Failure
Summary
The long-acting injectable growth hormone somapacitan-beco is also approved for other growth deficiencies in adults and children.
Description from Medscape.
Who is covering this
-
FDA Okays Once-Weekly Tx for Turner Syndrome Growth Failure
The long-acting injectable growth hormone somapacitan-beco is also approved for other growth deficiencies in adults and children.






Comments
Comments need JavaScript.